Developer docs
API playgroundTry for free, no card

Search company profiles

Crioestaminal

Full company profile

uuid000aam3

Namestring
Crioestaminal
Legal namestring
STEMLAB S.A.
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Crioestaminal, operated under the legal entity STEMLAB S.A., is a Portuguese family stem cell bank founded in 2003 by University of Coimbra researchers. The company collects, processes, and cryopreserves stem cells from umbilical cord blood, umbilical cord tissue, placenta, and adipose tissue at -196°C in liquid nitrogen, with stated viability for up to 25 years. It holds the first Portuguese Ministry of Health authorization for family stem cell banking (2011, Lei 12/2009), AABB international accreditation for cord blood and somatic cells, NP EN ISO 9001 certification (since 2006), and the only INFARMED GMP certification for cell therapy drug manufacturing among Portuguese cryopreservation banks (2025). Beyond storage, the company operates a 150 m² GMP-certified facility producing experimental cell therapy medicines for clinical trials in stroke, autoimmune disease, and severe inflammatory conditions, and offers cell expansion services using proprietary methods to enable adult transplant viability. It also holds four registered patents covering stem cell compositions, cardiac tissue preservation, exosome-based wound repair, and dendritic cell generation.

The business model is direct-to-consumer subscription, serving primarily expectant parents in Portugal through inside sales, maternity-ward referral networks, and digital marketing. Pricing is structured in tiers ranging from Essencial (~€645 total) to Família + Segura (€3,500 or €1,850 + €130/year), with annual storage fees of €70–€130 creating a recurring revenue base. The customer base exceeds 120,000 families, with 22 documented children treated using stored samples for conditions including SCID, severe aplastic anemia, cerebral palsy, and autism. Since 2018, the company has operated as the Portuguese subsidiary of the Famicord Group, the largest European stem cell bank, providing access to 34 countries, 1,500 hospital partnerships, and over 7,368 treatments performed group-wide. Adjacent services include the Lipostem sub-brand for adult adipose-tissue banking, a Patient Navigator service to assist families during therapy release, and a directed collection program for at-risk families.

Short descriptiontext

Crioestaminal is a Portuguese family stem cell bank that cryopreserves umbilical cord blood, tissue, placenta, and adipose tissue at -196°C. Part of the Famicord Group, it serves over 120,000 families in Portugal with certified storage and GMP cell therapy manufacturing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCantanhede, Portugal
HQ citystring
Cantanhede
HQ countrystring
Portugal
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell banking, umbilical cord blood preservation, cryopreservation services, cell therapy manufacturing, regenerative medicine services
Industry5 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAKAC
Cell Therapy Manufacturing Services (GMP, autologous/allogeneic)
SECONDARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code3 codes
  • Blood and Organ Banks621991
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Commercial Physical & Biological Research8731
Product category
Stem Cell Banking Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Stem Cell Cryopreservation Services
TypeSubscription Recurring
Description

Primary revenue from cryopreservation services for umbilical cord blood and tissue. Payment structured in phases: adhesion fee during pregnancy, processing fee after birth, and annual storage fees. Multiple service tiers from basic to comprehensive family protection plans.

crioestaminal.pt
2Cell Expansion Services
TypeOne Time License
Description

Future preparation of mesenchymal stem cells from cord tissue for clinical use, offered as part of premium service packages

crioestaminal.pt
3Credit Intermediation
TypeProfessional Services
Description

Crioestaminal acts as credit intermediary on an accessory basis in non-exclusivity regime, offering installment payment options for families

crioestaminal.pt
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details5 tiers
1Essencial - Basic cord blood preservation
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Adhesion: 125€ (includes collection kit and transport), Processing: 450€ (after birth), Annual: 70€/year. Total approximately 645€

crioestaminal.pt
2Família - Cord blood and tissue preservation
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One-time payment: 1,775€ OR flexible payment: 600€ + 85€/year annual fee

crioestaminal.pt
3Família Segura (Best-seller) - Blood, tissue plus future cell preparation
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One-time payment: 2,000€ OR flexible payment: 750€ + 100€/year annual fee

crioestaminal.pt
4Família + - Best value with immediate cell expansion
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One-time payment: 2,400€ OR flexible payment: 850€ + 115€/year annual fee

crioestaminal.pt
5Família + Segura - Complete protection with immediate expansion
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One-time payment: 3,500€ OR flexible payment: 1,850€ + 130€/year annual fee

crioestaminal.pt
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Lipostem
Description

Adult stem cell storage service for adipose tissue stem cells, targeted at non-expecting parents.

crioestaminal.pt
Core offering1 text field

Crioestaminal collects, processes, and cryopreserves stem cells from umbilical cord blood, umbilical cord tissue, placenta, and adipose tissue at -196°C using liquid nitrogen for long-term storage of up to 25 years. The company operates a GMP-certified 150 m² cell therapy medicine production facility for clinical trial and experimental therapies, and provides add-on services including proprietary cell expansion, directed collections for at-risk families, a research bank, and a Patient Navigator support program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 22 children treated with cryopreserved stem cell samples from Crioestaminal
+3 more records
Product overview1 text field

Crioestaminal is a family cord blood and tissue bank operating since 2003, offering cryopreservation services for multiple types of stem cells including umbilical cord blood (Sangue do Cordão Umbilical), umbilical cord tissue (Tecido do Cordão Umbilical), placenta, and adipose tissue. The core service includes collection kits, laboratory processing, and long-term storage at -196°C for up to 25 years. The company operates a GMP-certified cellular therapy drug manufacturing unit and offers add-on services such as cellular expansion, Patient Navigator support, and a research bank for donated samples. Storage plans range from entry-level (Essencial) to premium (Família +), with the best-selling Família Segura plan including future mesenchymal stem cell preparation. Crioestaminal is part of the Famicord Group, the largest European stem cell bank group.

Product and service9 records
1Umbilical Cord Blood Cryopreservation (Sangue do Cordão Umbilical)
CategoryStem Cell Storage
Description

Cryopreservation service for hematopoietic stem cells from umbilical cord blood, used in the treatment of more than 90 hematological, oncological, and metabolic diseases. The cells are similar to those found in bone marrow and applicable for blood disorders and cancers.

2Umbilical Cord Tissue Cryopreservation (Tecido do Cordão Umbilical)
CategoryStem Cell Storage
Description

Cryopreservation service for mesenchymal stem cells from umbilical cord tissue, with applications in regenerative medicine for autoimmune diseases, cartilage, bone, and muscle regeneration.

3Placenta Cryopreservation
CategoryStem Cell Storage
Description

Cryopreservation service for placental stem cells, rich in mesenchymal stem cells and epithelial cells with anti-inflammatory properties, under study for various diseases including graft-versus-host disease and peripheral arterial disease.

4Adipose Tissue Cryopreservation (Tecido Adiposo)
CategoryStem Cell Storage
Description

Cryopreservation service for mesenchymal stem cells derived from adipose tissue (fat), with potential applications in autoimmune, neurodegenerative diseases, and bone/cartilage regeneration. Offered via the Lipostem sub-brand targeted at non-expecting parents.

5Cell Expansion Service (Expansão Celular)
CategoryCell Processing Service
Description

Service for expanding stem cell numbers from cord blood samples to ensure viability for adult transplants, using proprietary in-house methods. Available as a component of premium service packages.

6Cell Therapy Medicine Production Unit (GMP)
CategoryCell Therapy Manufacturing
Description

INFARMED GMP-certified 150 m² cellular therapy drug manufacturing unit that produces experimental medications for clinical trials and therapies in areas such as stroke, autoimmune diseases, severe inflammatory conditions, and COVID-19. The only cryopreservation bank in Portugal with this certification.

7Patient Navigator Service
CategoryPatient Support Service
Description

Dedicated professional service guiding and assisting families through the process of releasing stored samples for therapy, handling bureaucratic tasks across healthcare systems.

8Research Bank (Banco de Investigação)
CategoryResearch Service
Description

Research bank service for donated stem cells, allowing researchers access to samples for discovering new therapeutic solutions when families choose not to store for themselves.

9Directed Collections (Colheitas Dirigidas)
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Crioestaminal has been part of Famicord Group since 2018. Famicord is the largest European stem cell bank group with 1,000,000+ stored samples, present in 34 countries, with 1,500 hospital partnerships and 7,368+ treatments performed. Crioestaminal serves as the group's Portuguese operation.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German family cord blood bank and Famicord Group subsidiary offering umbilical cord blood and tissue cryopreservation under a near-identical service model, payment structure, and regulatory framework (PEI/GMP). Directly comparable in scale, product portfolio, and GTM.

TypeDirect peer
Description

Polish family cord blood bank and Famicord Group subsidiary with comparable service tiers, multi-year storage contracts, and GMP-licensed processing. Same parent group, parallel service design, and overlapping geographic reach.

TypeDirect peer
Description

Spanish family cord blood bank within the Famicord Group, offering cryopreservation of cord blood and tissue plus cell expansion services. Operates a parallel Iberian market presence with similar regulatory positioning under Spanish Ministry of Health authorization.

TypeDirect peer
Description

UK-based family stem cell bank that joined the Famicord Group, offering umbilical cord blood and tissue storage with comparable subscription-based pricing and AABB-equivalent (HTA) accreditation. Direct peer for the Portuguese company's international B2C proposition.

5Biogenis
TypeDirect peer
Description

Romanian stem cell bank within the Famicord Group providing cord blood and tissue cryopreservation plus advanced therapy manufacturing support. Comparable in service mix, regulatory positioning, and role as a regional Famicord operating unit.

TypeDirect peer
Description

Nordic family cord blood bank (Sweden/Denmark) within the Famicord Group, offering cord blood and tissue storage under similar subscription models with comparable regulatory certifications. Functions as the Nordic equivalent of Crioestaminal's Portuguese operation.

TypeBroad incumbent
Description

Parent group and largest European stem cell bank with 1M+ stored samples across 34 countries. Comparable as the umbrella organization providing Crioestaminal with international scale, central lab standards, and clinical-trial reach.

TypeBroad incumbent
Description

Largest US family cord blood bank, now part of Generate Life Sciences. Comparable in customer scale (500K+ families), service portfolio (cord blood + tissue + cell expansion), and consumer trust positioning, though operating in a different regulatory and reimbursement environment.

TypeBroad incumbent
Description

US-based family cord blood and tissue bank owned by PerkinElmer, offering comparable cryopreservation services plus emerging perinatal tissue storage. Relevant benchmark for service expansion into placenta and tissue banking.

10Cryo-Save (now BioVault)
TypeRegional player
Description

European family stem cell bank with historical presence in Portugal and across Europe. Once a direct competitor, now operating under BioVault Family in a more limited geographic footprint. Comparable service model and historical competitive overlap.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Crioestaminal

Stem Cell Banking Servicescrioestaminal.pt

Crioestaminal is a Portuguese family stem cell bank that cryopreserves umbilical cord blood, tissue, placenta, and adipose tissue at -196°C. Part of the Famicord Group, it serves over 120,000 families in Portugal with certified storage and GMP cell therapy manufacturing services.

What Crioestaminal does

Crioestaminal, operated under the legal entity STEMLAB S.A., is a Portuguese family stem cell bank founded in 2003 by University of Coimbra researchers. The company collects, processes, and cryopreserves stem cells from umbilical cord blood, umbilical cord tissue, placenta, and adipose tissue at -196°C in liquid nitrogen, with stated viability for up to 25 years. It holds the first Portuguese Ministry of Health authorization for family stem cell banking (2011, Lei 12/2009), AABB international accreditation for cord blood and somatic cells, NP EN ISO 9001 certification (since 2006), and the only INFARMED GMP certification for cell therapy drug manufacturing among Portuguese cryopreservation banks (2025). Beyond storage, the company operates a 150 m² GMP-certified facility producing experimental cell therapy medicines for clinical trials in stroke, autoimmune disease, and severe inflammatory conditions, and offers cell expansion services using proprietary methods to enable adult transplant viability. It also holds four registered patents covering stem cell compositions, cardiac tissue preservation, exosome-based wound repair, and dendritic cell generation.

The business model is direct-to-consumer subscription, serving primarily expectant parents in Portugal through inside sales, maternity-ward referral networks, and digital marketing. Pricing is structured in tiers ranging from Essencial (~€645 total) to Família + Segura (€3,500 or €1,850 + €130/year), with annual storage fees of €70–€130 creating a recurring revenue base. The customer base exceeds 120,000 families, with 22 documented children treated using stored samples for conditions including SCID, severe aplastic anemia, cerebral palsy, and autism. Since 2018, the company has operated as the Portuguese subsidiary of the Famicord Group, the largest European stem cell bank, providing access to 34 countries, 1,500 hospital partnerships, and over 7,368 treatments performed group-wide. Adjacent services include the Lipostem sub-brand for adult adipose-tissue banking, a Patient Navigator service to assist families during therapy release, and a directed collection program for at-risk families.

Crioestaminal firmographics

Firmographics
Name
Crioestaminal
Legal name
STEMLAB S.A.
Website
https://crioestaminal.pt
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Crioestaminal is a Portuguese family stem cell bank that cryopreserves umbilical cord blood, tissue, placenta, and adipose tissue at -196°C. Part of the Famicord Group, it serves over 120,000 families in Portugal with certified storage and GMP cell therapy manufacturing services.
Ownership category
akta.pro rank

Crioestaminal industry classification

Industry
Product category
Stem Cell Banking Services
NAICS
Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAKAC
Cell Therapy Manufacturing Services (GMP, autologous/allogeneic)
SECONDARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Stem cell banking
  • Umbilical cord blood preservation
  • Cryopreservation services
  • Cell therapy manufacturing
  • Regenerative medicine services

Where Crioestaminal is headquartered

Location

Headquarters

HQ city
Cantanhede
HQ country
Portugal
HQ region
Europe

Offices1 record

Markets served

Crioestaminal business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Stem Cell Cryopreservation Services: Primary revenue from cryopreservation services for umbilical cord blood and tissue. Payment structured in phases: adhesion fee during pregnancy, processing fee after birth, and annual storage fees. Multiple service tiers from basic to comprehensive family protection plans.
  2. Cell Expansion Services: Future preparation of mesenchymal stem cells from cord tissue for clinical use, offered as part of premium service packages
  3. Credit Intermediation: Crioestaminal acts as credit intermediary on an accessory basis in non-exclusivity regime, offering installment payment options for families

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEssencial - Basic cord blood preservation
SubscriptionMulti-year contractFamília - Cord blood and tissue preservation
SubscriptionMulti-year contractFamília Segura (Best-seller) - Blood, tissue plus future cell preparation
SubscriptionMulti-year contractFamília + - Best value with immediate cell expansion
SubscriptionMulti-year contractFamília + Segura - Complete protection with immediate expansion

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Crioestaminal product offering

Product offering

Core offering

Crioestaminal collects, processes, and cryopreserves stem cells from umbilical cord blood, umbilical cord tissue, placenta, and adipose tissue at -196°C using liquid nitrogen for long-term storage of up to 25 years. The company operates a GMP-certified 150 m² cell therapy medicine production facility for clinical trial and experimental therapies, and provides add-on services including proprietary cell expansion, directed collections for at-risk families, a research bank, and a Patient Navigator support program.

Product overview

Crioestaminal is a family cord blood and tissue bank operating since 2003, offering cryopreservation services for multiple types of stem cells including umbilical cord blood (Sangue do Cordão Umbilical), umbilical cord tissue (Tecido do Cordão Umbilical), placenta, and adipose tissue. The core service includes collection kits, laboratory processing, and long-term storage at -196°C for up to 25 years. The company operates a GMP-certified cellular therapy drug manufacturing unit and offers add-on services such as cellular expansion, Patient Navigator support, and a research bank for donated samples. Storage plans range from entry-level (Essencial) to premium (Família +), with the best-selling Família Segura plan including future mesenchymal stem cell preparation. Crioestaminal is part of the Famicord Group, the largest European stem cell bank group.

Differentiator

Problem solved

Functional benefit

Brands

  • Lipostem: Adult stem cell storage service for adipose tissue stem cells, targeted at non-expecting parents.

Products and services

  • Umbilical Cord Blood Cryopreservation (Sangue do Cordão Umbilical) Cryopreservation service for hematopoietic stem cells from umbilical cord blood, used in the treatment of more than 90 hematological, oncological, and metabolic diseases. The cells are similar to those found in bone marrow and applicable for blood disorders and cancers.
  • Umbilical Cord Tissue Cryopreservation (Tecido do Cordão Umbilical) Cryopreservation service for mesenchymal stem cells from umbilical cord tissue, with applications in regenerative medicine for autoimmune diseases, cartilage, bone, and muscle regeneration.
  • Placenta Cryopreservation Cryopreservation service for placental stem cells, rich in mesenchymal stem cells and epithelial cells with anti-inflammatory properties, under study for various diseases including graft-versus-host disease and peripheral arterial disease.
  • Adipose Tissue Cryopreservation (Tecido Adiposo) Cryopreservation service for mesenchymal stem cells derived from adipose tissue (fat), with potential applications in autoimmune, neurodegenerative diseases, and bone/cartilage regeneration. Offered via the Lipostem sub-brand targeted at non-expecting parents.
  • Cell Expansion Service (Expansão Celular) Service for expanding stem cell numbers from cord blood samples to ensure viability for adult transplants, using proprietary in-house methods. Available as a component of premium service packages.
  • Cell Therapy Medicine Production Unit (GMP) INFARMED GMP-certified 150 m² cellular therapy drug manufacturing unit that produces experimental medications for clinical trials and therapies in areas such as stroke, autoimmune diseases, severe inflammatory conditions, and COVID-19. The only cryopreservation bank in Portugal with this certification.
  • Patient Navigator Service Dedicated professional service guiding and assisting families through the process of releasing stored samples for therapy, handling bureaucratic tasks across healthcare systems.
  • Research Bank (Banco de Investigação) Research bank service for donated stem cells, allowing researchers access to samples for discovering new therapeutic solutions when families choose not to store for themselves.
  • Directed Collections (Colheitas Dirigidas)

Quantifiable outcome

  • 22 children treated with cryopreserved stem cell samples from Crioestaminal
  • +3 more outcomes

Companies that use Crioestaminal

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles4 records

Crioestaminal technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Crioestaminal partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Famicord GroupflagshipStrategic or Co-development PartnerCrioestaminal has been part of Famicord Group since 2018. Famicord is the largest European stem cell bank group with 1,000,000+ stored samples, present in 34 countries, with 1,500 hospital partnerships and 7,368+ treatments performed. Crioestaminal serves as the group's Portuguese operation.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Crioestaminal competitors and assessment

Company assessment

Direct peers

  • Vita 34: German family cord blood bank and Famicord Group subsidiary offering umbilical cord blood and tissue cryopreservation under a near-identical service model, payment structure, and regulatory framework (PEI/GMP). Directly comparable in scale, product portfolio, and GTM.
  • PBKM (Polski Bank Komórek Macierzystych): Polish family cord blood bank and Famicord Group subsidiary with comparable service tiers, multi-year storage contracts, and GMP-licensed processing. Same parent group, parallel service design, and overlapping geographic reach.
  • Sevibe Cells: Spanish family cord blood bank within the Famicord Group, offering cryopreservation of cord blood and tissue plus cell expansion services. Operates a parallel Iberian market presence with similar regulatory positioning under Spanish Ministry of Health authorization.
  • Smart Cells: UK-based family stem cell bank that joined the Famicord Group, offering umbilical cord blood and tissue storage with comparable subscription-based pricing and AABB-equivalent (HTA) accreditation. Direct peer for the Portuguese company's international B2C proposition.
  • Biogenis: Romanian stem cell bank within the Famicord Group providing cord blood and tissue cryopreservation plus advanced therapy manufacturing support. Comparable in service mix, regulatory positioning, and role as a regional Famicord operating unit.
  • Cellaviva: Nordic family cord blood bank (Sweden/Denmark) within the Famicord Group, offering cord blood and tissue storage under similar subscription models with comparable regulatory certifications. Functions as the Nordic equivalent of Crioestaminal's Portuguese operation.

Broad incumbents

  • Famicord Group: Parent group and largest European stem cell bank with 1M+ stored samples across 34 countries. Comparable as the umbrella organization providing Crioestaminal with international scale, central lab standards, and clinical-trial reach.
  • Cord Blood Registry (CBR): Largest US family cord blood bank, now part of Generate Life Sciences. Comparable in customer scale (500K+ families), service portfolio (cord blood + tissue + cell expansion), and consumer trust positioning, though operating in a different regulatory and reimbursement environment.
  • ViaCord: US-based family cord blood and tissue bank owned by PerkinElmer, offering comparable cryopreservation services plus emerging perinatal tissue storage. Relevant benchmark for service expansion into placenta and tissue banking.

Regional players

  • Cryo-Save (now BioVault): European family stem cell bank with historical presence in Portugal and across Europe. Once a direct competitor, now operating under BioVault Family in a more limited geographic footprint. Comparable service model and historical competitive overlap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Crioestaminal social profiles

Digital presence

Crioestaminal compliance and trust

Trust signal

Compliance6 records

Crioestaminal financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Crioestaminal leadership team

Management profile

Number of profiles

Profiles4 records

Crioestaminal funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Crioestaminal M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Crioestaminal

What does Crioestaminal do?

Crioestaminal collects, processes, and cryopreserves stem cells from umbilical cord blood, umbilical cord tissue, placenta, and adipose tissue at -196°C using liquid nitrogen for long-term storage of up to 25 years. The company operates a GMP-certified 150 m² cell therapy medicine production facility for clinical trial and experimental therapies, and provides add-on services including proprietary cell expansion, directed collections for at-risk families, a research bank, and a Patient Navigator support program.

Is Crioestaminal a public or private company?

Crioestaminal is a private company. It is classified as corporate owned and is currently operating.

When was Crioestaminal founded?

Crioestaminal was founded in 2003. It employs 11 to 50 people.

Where is Crioestaminal based?

Crioestaminal is headquartered in Cantanhede, Portugal, in the Europe region.

How does Crioestaminal make money?

Three revenue lines are on record. Stem Cell Cryopreservation Services are the primary driver. The others are cell Expansion Services and credit Intermediation.

Who are Crioestaminal's main competitors?

Direct peers on record are Vita 34, PBKM (Polski Bank Komórek Macierzystych), Sevibe Cells, Smart Cells, Biogenis and Cellaviva. Broad incumbents are Famicord Group, Cord Blood Registry (CBR) and ViaCord. Cryo-Save (now BioVault) is listed as a regional player.

Does Crioestaminal have an API?

No public API is recorded for Crioestaminal.

What industry is Crioestaminal in?

Crioestaminal's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAAAJAN, Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies. Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals